Substituted β-cyclodextrins interact with PAMAM dendrimer-DNA complexes and modify transfection efficiency

被引:56
作者
Roessler, BJ [1 ]
Bielinska, AU
Janczak, K
Lee, I
Baker, JR
机构
[1] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Ctr Biol Nanotechnol, Ann Arbor, MI 48109 USA
关键词
D O I
10.1006/bbrc.2001.4690
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The efficiency of PAMAM dendrimer-mediated DNA transfer can be improved by the addition of substituted beta -cyclodextrins (beta -CDs) as formulation excipients. In vitro CAT expression increased approximately 200-fold when dendrimer/DNA/beta -CD formulations were applied on the surface of collagen membranes. The inclusion of beta -CD into the formulations resulted in particles that were smaller and more evenly distributed on the surface of the solid support. The average size of the complex formed at 50 mug/ml anal at charge ratio of 1 decreased from 156 nm to 5.8 nm and 21.2 nm in 0.025-0.1% w/vol beta -CDs. Sulfonated beta -CDs bind to dendrimer and in the increased concentration may displace DNA in the dendrimer/DNA complex. High concentrations of amphoteric beta -CD do not dissociate dendrimer/DNA complexes; however, they may decrease their ability to transfect cells. At the optimized formulations the surface-modified beta -CDs may enhance solid support-based transfection in vitro, through modification of dendrimer/DNA complex composition and improved surface distribution. (C) 2001 Academic Press.
引用
收藏
页码:124 / 129
页数:6
相关论文
共 17 条
[1]   Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems [J].
Bibby, DC ;
Davies, NM ;
Tucker, IG .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 197 (1-2) :1-11
[2]   DNA complexing with polyamidoamine dendrimers: Implications for transfection [J].
Bielinska, AU ;
Chen, CL ;
Johnson, J ;
Baker, JR .
BIOCONJUGATE CHEMISTRY, 1999, 10 (05) :843-850
[3]   The interaction of plasmid DNA with polyamidoamine dendrimers: mechanism of complex formation and analysis of alterations induced in nuclease sensitivity and transcriptional activity of the complexed DNA [J].
Bielinska, AU ;
KukowskaLatallo, JF ;
Baker, JR .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1997, 1353 (02) :180-190
[4]   Application of membrane-based dendrimer/DNA complexes for solid phase transfection in vitro and in vivo [J].
Bielinska, AU ;
Yen, A ;
Wu, HL ;
Zahos, KM ;
Sun, R ;
Weiner, ND ;
Baker, JR ;
Roessler, BJ .
BIOMATERIALS, 2000, 21 (09) :877-887
[5]   The stability of cyclodextrin complexes in solution [J].
Connors, KA .
CHEMICAL REVIEWS, 1997, 97 (05) :1325-1357
[6]  
Eichman, 2000, Pharm Sci Technol Today, V3, P232, DOI 10.1016/S1461-5347(00)00273-X
[7]   The influence of sodium glycocholate and other additives on the in vivo transfection of plasmid DNA in the lungs [J].
Freeman, DJ ;
Niven, RW .
PHARMACEUTICAL RESEARCH, 1996, 13 (02) :202-209
[8]   New class of polymers for the delivery of macromolecular therapeutics [J].
Gonzalez, H ;
Hwang, SJ ;
Davis, ME .
BIOCONJUGATE CHEMISTRY, 1999, 10 (06) :1068-1074
[9]   Activated polyamidoamine dendrimers, a non-viral vector for gene transfer to the corneal endothelium [J].
Hudde, T ;
Rayner, SA ;
Comer, RM ;
Weber, M ;
Isaacs, JD ;
Waldmann, H ;
Larkin, DPF ;
George, AJT .
GENE THERAPY, 1999, 6 (05) :939-943
[10]   Pharmaceutical applications of cyclodextrins .3. Toxicological issues and safety evaluation [J].
Irie, T ;
Uekama, K .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (02) :147-162